These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27886546)
1. Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl carboxylate derivatives. Salar U; Khan KM; Taha M; Ismail NH; Ali B; Qurat-Ul-Ain ; Perveen S; Ghufran M; Wadood A Eur J Med Chem; 2017 Jan; 125():1289-1299. PubMed ID: 27886546 [TBL] [Abstract][Full Text] [Related]
2. Biology-oriented drug synthesis (BIODS) of 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl aryl ether derivatives, in vitro α-amylase inhibitory activity and in silico studies. Taha M; Imran S; Ismail NH; Selvaraj M; Rahim F; Chigurupati S; Ullah H; Khan F; Salar U; Javid MT; Vijayabalan S; Zaman K; Khan KM Bioorg Chem; 2017 Oct; 74():1-9. PubMed ID: 28719801 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro β-glucuronidase inhibitory activity and in silico studies of novel (E)-4-Aryl-2-(2-(pyren-1-ylmethylene)hydrazinyl)thiazoles. Salar U; Khan KM; Syed S; Taha M; Ali F; Ismail NH; Perveen S; Wadood A; Ghufran M Bioorg Chem; 2017 Feb; 70():199-209. PubMed ID: 28069264 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As β-glucuronidase inhibitors. Taha M; Baharudin MS; Ismail NH; Selvaraj M; Salar U; Alkadi KA; Khan KM Bioorg Chem; 2017 Apr; 71():86-96. PubMed ID: 28160943 [TBL] [Abstract][Full Text] [Related]
5. Thiadiazole derivatives as New Class of β-glucuronidase inhibitors. Salar U; Taha M; Ismail NH; Khan KM; Imran S; Perveen S; Wadood A; Riaz M Bioorg Med Chem; 2016 Apr; 24(8):1909-18. PubMed ID: 26994638 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines. Bano B; Arshia ; Khan KM; Kanwal ; Fatima B; Taha M; Ismail NH; Wadood A; Ghufran M; Perveen S Eur J Med Chem; 2017 Oct; 139():849-864. PubMed ID: 28865280 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and β-glucuronidase inhibitory potential of benzimidazole derivatives. Khan KM; Khan M; Ambreen N; Rahim F; Naureen S; Perveen S; Choudhary MI; Voelter W Med Chem; 2012 May; 8(3):421-7. PubMed ID: 22530898 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies. Khan KM; Rahim F; Wadood A; Taha M; Khan M; Naureen S; Ambreen N; Hussain S; Perveen S; Choudhary MI Bioorg Med Chem Lett; 2014 Apr; 24(7):1825-9. PubMed ID: 24602903 [TBL] [Abstract][Full Text] [Related]
9. 2,5-Disubstituted thiadiazoles as potent β-glucuronidase inhibitors; Synthesis, in vitro and in silico studies. Taha M; Barak Almandil N; Rashid U; Ali M; Ibrahim M; Gollapalli M; Mosaddik A; Mohammed Khan K Bioorg Chem; 2019 Oct; 91():103126. PubMed ID: 31349116 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors. Chen S; Zhang T; Wang J; Wang F; Niu H; Wu C; Wang S Eur J Med Chem; 2015 Oct; 103():343-53. PubMed ID: 26363870 [TBL] [Abstract][Full Text] [Related]
11. 1-[(4'-Chlorophenyl) carbonyl-4-(aryl) thiosemicarbazide derivatives as potent urease inhibitors: Synthesis, in vitro and in silico studies. Ali B; Khan KM; Salar U; Kanwal ; Hussain S; Ashraf M; Riaz M; Wadood A; Taha M; Perveen S Bioorg Chem; 2018 Sep; 79():363-371. PubMed ID: 29859384 [TBL] [Abstract][Full Text] [Related]
12. Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies. Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Ali M; Abdullah N; Khan KM Bioorg Med Chem; 2015 Jul; 23(13):3119-25. PubMed ID: 26001340 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors. Taha M; Ismail NH; Imran S; Selvaraj M; Rashwan H; Farhanah FU; Rahim F; Kesavanarayanan KS; Ali M Bioorg Chem; 2015 Aug; 61():36-44. PubMed ID: 26073618 [TBL] [Abstract][Full Text] [Related]
14. Biology-oriented drug synthesis (BIODS), in vitro urease inhibitory activity, and in silico studies on ibuprofen derivatives. Seraj F; Kanwal ; Khan KM; Khan A; Ali M; Khalil R; Ul-Haq Z; Hameed S; Taha M; Salar U; Perveen S Mol Divers; 2021 Feb; 25(1):143-157. PubMed ID: 31965436 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies. Taha M; Ismail NH; Imran S; Rashwan H; Jamil W; Ali S; Kashif SM; Rahim F; Salar U; Khan KM Bioorg Chem; 2016 Apr; 65():48-56. PubMed ID: 26855413 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of bis-indolylmethanes as new potential inhibitors of β-glucuronidase and their molecular docking studies. Taha M; Ullah H; Al Muqarrabun LMR; Khan MN; Rahim F; Ahmat N; Ali M; Perveen S Eur J Med Chem; 2018 Jan; 143():1757-1767. PubMed ID: 29133042 [TBL] [Abstract][Full Text] [Related]
17. 2-Oxo-1,2,3,4-tetrahydropyrimidines Ethyl Esters as Potent β- Glucuronidase Inhibitors: One-pot Synthesis, In vitro and In silico Studies. Iqbal S; Shaikh NN; Khan KM; Naz S; Ul-Haq Z; Perveen S; Choudhary MI Med Chem; 2018; 14(8):818-830. PubMed ID: 29793412 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel disulfide and sulfone hybrid scaffolds as potent β-glucuronidase inhibitor. Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Al Muqarrabin LM; Zaki HM; Ahmat N; Nasir A; Khan F Bioorg Chem; 2016 Oct; 68():15-22. PubMed ID: 27414468 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of 2-Aminopyrimidine Derivatives and Their Evaluation as Iqbal S; Shaikh NN; Khan KM; Kiran S; Naz S; Ul-Haq Z; Perveen S; Choudhary MI Molecules; 2022 Nov; 27(22):. PubMed ID: 36431887 [TBL] [Abstract][Full Text] [Related]
20. 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors. Courtney SM; Hay PA; Buck RT; Colville CS; Porter DW; Scopes DI; Pollard FC; Page MJ; Bennett JM; Hircock ML; McKenzie EA; Stubberfield CR; Turner PR Bioorg Med Chem Lett; 2004 Jun; 14(12):3269-73. PubMed ID: 15149688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]